Continuous hemofiltration model using porcine blood for comparing filter life

J Artif Organs. 2018 Sep;21(3):332-339. doi: 10.1007/s10047-018-1060-3. Epub 2018 Jul 24.

Abstract

The purpose of the present study was to establish a continuous hemofiltration model using porcine blood to compare filter life. Continuous hemofiltration (CHF) experiments were performed using an in vitro hemofilter evaluation system utilizing porcine blood containing trisodium citrate in addition to nafamostat mesilate as anticoagulants. The lifetime of the hemofilter was evaluated using the transmembrane pressure and the pressure drop across the hemofilter at varying trisodium citrate concentrations. The porcine blood used in this experiment was considered to be in a slightly hypercoagulable state because of the continuous contact with non-biological materials and calcium inflow from substitution fluid. Blood containing 7 or 8 mM of trisodium citrate and nafamostat mesilate could be effectively used to compare the lifetimes of hemofilters utilized under the same conditions. In this CHF model using porcine blood, the plugging of the hollow fibers occurred shortly after the plugging of the membrane pores. In conclusion, a CHF model using porcine blood can be established by adjusting the concentration of trisodium citrate added to the blood.

Keywords: Continuous hemofiltration; Filter life; Fouling; Porcine blood; Trisodium citrate.

MeSH terms

  • Animals
  • Anticoagulants / therapeutic use
  • Benzamidines
  • Citrates / therapeutic use
  • Guanidines / therapeutic use
  • Hemofiltration / instrumentation
  • Hemofiltration / methods*
  • Swine

Substances

  • Anticoagulants
  • Benzamidines
  • Citrates
  • Guanidines
  • trisodium citrate
  • nafamostat